Supplier

EGETIS THERAPEUTICS AB

Opportunities

No declared value on record

A Germany supplier, with 2 awarded contracts, most recently 12 months ago.

Germany(inferred)

Opportunities

No declared value on record

Contract history

2 entries

Most recent
31 Aug 2025
12 months ago
Biggest
€1
Non-Exclusive Discount Agreement fo…
Average size
€1
Across 2 priced
Last 12 months
1
entry

Won · 2

Non-Exclusive Discount Agreement for Emcitate(R)€1 · 31 Aug 2025 Germany – Awarded Contracts for Medicines€1 · 3 Jul 2025

Jun 25Jul 25Aug 25Aug 25Sept 25

Opportunities

Showing awarded · 2

AwardedHealthcare & MedicalGermany

Non-Exclusive Discount Agreement for Emcitate(R)

This contract involves a non-exclusive discount agreement between IKK classic and Egetis Therapeutics AB for the medication Emcitate(R), which contains the active ingredient Tiratricol (ATC code: H03AA04). The agreement is set to run from September 1, 2025, to August 31, 2027. Suppliers are invited

€1nominalIKK CLASSIC

Published 31 Aug 2025

AwardedHealthcare & MedicalGermany

Germany – Awarded Contracts for Medicines

This contract pertains to the procurement of the medicine Emcitate, as part of a framework discount agreement between health insurance companies and pharmaceutical companies. The GWQ ServicePlus AG, acting on behalf of its shareholder and client health insurance funds, is conducting a formal procure

€1nominalGWQ SERVICEPLUS AG

Published 3 Jul 2025